+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Spatial Genomics & Transcriptomics Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 187 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 6012040
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The spatial genomics and transcriptomics market is experiencing rapid advancement as institutions integrate next-generation analytical tools for higher-resolution molecular mapping in tissue environments. Senior decision-makers must stay ahead of these evolutions to prioritize effective investments, sourcing, and research strategies.

Market Snapshot: Spatial Genomics & Transcriptomics Market Outlook

The spatial genomics and transcriptomics market progressed from USD 1.18 billion in 2024 to USD 1.32 billion in 2025, with projections indicating growth to USD 3.07 billion by 2032 at a compound annual growth rate (CAGR) of 12.71%. This robust expansion results from broad uptake of spatial molecular analysis across research institutions, clinical labs, and biopharmaceutical organizations. As end-users pursue advanced solutions for mapping gene expression and molecular modifications at the single-cell level, momentum rises in translational research, tumor profiling, and drug discovery workflows. These shifts create significant opportunities for leaders to drive data-based strategy and innovation.

Scope & Segmentation of the Spatial Genomics and Transcriptomics Market

This comprehensive report covers the entire spatial genomics and transcriptomics value chain, delivering actionable insights for benchmarking and strategic planning in a changing landscape. The analysis enables senior stakeholders to assess technologies, application areas, and operational environments for optimal investment.

  • Product Categories: Consumables include assay kits and reagents essential for molecular workflows, while instruments range from microscopes to advanced sequencing platforms. Software solutions feature powerful data analysis and visualization applications to support interpretation.
  • Sequencing Methods: Techniques under analysis span in situ sequencing approaches, multiplexed error-robust fluorescence in situ hybridization, sequential fluorescence in situ hybridization, Slide-seq, as well as additional spatial transcriptomics workflows.
  • Applications: Critical use cases encompass cancer research, oncology profiling, tumor microenvironment analysis, developmental biology, drug discovery (including biomarker analysis and therapeutic target identification), as well as immunology and neurology.
  • End-Users: Target audiences consist of academic research institutions, clinical research entities, pharmaceutical and biotechnology companies, plus research laboratories such as core facilities and private service labs.
  • Regional Coverage: The report reviews market dynamics and adoption trends across the Americas, Europe, Middle East & Africa, and Asia-Pacific regions, focusing on local adaptation, workforce capacity, and regulatory integration.
  • Company Analysis: Competitive profiling covers leaders and emerging players, such as 10x Genomics, Inc., Illumina, Inc., Agilent Technologies, Inc., and additional innovators advancing spatial omics solutions.

Key Takeaways for Decision-Makers

  • Combining spatial genomics with transcriptomics achieves a more comprehensive understanding by connecting gene activity to tissue structure, resulting in improved translational and clinical outcomes.
  • Innovations in multiplexed sequencing and imaging, supported by artificial intelligence, enhance workflow efficiency and elevate the precision of molecular insights, positioning organizations to capitalize on emerging research frontiers.
  • Cross-sector collaboration among instrument manufacturers, software developers, and academic groups establishes open-source tools, fostering technical standardization and growing accessibility to spatial omics technologies.
  • Regional efforts, especially within the Asia-Pacific and European areas, advance market development through local technology adaptation, workforce training, and harmonized regulatory support tailored to specific disease research needs.
  • The competitive landscape is shifting as new entrants focus on areas like high-plex barcoding and integrated molecular profiling, while established companies pursue alliances and acquisitions to reinforce market presence.

Tariff Impact: Navigating 2025 U.S. Import Policy Changes

Forthcoming adjustments to the U.S. tariff schedule in 2025 will directly impact the spatial genomics and transcriptomics supply chain. Increased import duties on reagents and precision optics are prompting organizations to re-examine procurement policies and cultivate new vendor relationships. These changes are expected to accelerate domestic manufacturing and regionalized sourcing of consumables, promoting greater supply resilience and cost management. Leadership should prioritize transparent supply tracking, align compliance strategies, and develop agile risk management practices to secure operational continuity with evolving regulatory standards.

Spatial Genomics and Transcriptomics Market: Methodology & Data Sources

This market report employs a methodology combining primary and secondary research, including systematic literature reviews, patent monitoring, and regulatory analysis. Interviews with industry leaders and procurement specialists further refine findings, ensuring reliable representation of segment trends and supporting executive decision-making.

Why This Report Matters for Strategic Leadership

  • Inform investment and operational strategies by evaluating segments, competitor profiles, and technology trends within the spatial genomics and transcriptomics market.
  • Proactively adapt to regulatory, supply chain, and tariff developments to maintain R&D flexibility and operational efficiency.
  • Leverage detailed analysis of product innovation, workflow evolution, and fast-growing geographic markets to access new opportunities and improve performance.

Conclusion

Spatial genomics and transcriptomics are transforming molecular analysis and propelling advances in precision medicine. This report supports senior leaders in allocating resources, navigating regulatory changes, and directing innovation in this dynamic market environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Integration of high-plex spatial transcriptomics with single-cell multi-omics for comprehensive cellular mapping
5.2. Adoption of in situ sequencing methods enabling transcriptome-wide analysis at subcellular spatial resolution
5.3. Development of AI-driven image analysis pipelines for automated identification of spatial gene expression patterns
5.4. Emergence of high-throughput automated tissue handling platforms to scale spatial genomics experiments
5.5. Commercialization of spatial epigenomics workflows for simultaneous profiling of chromatin accessibility and location
5.6. Partnerships between academic consortia and biotech firms to build open spatial gene expression atlases across human tissues
5.7. Expansion of liquid biopsy spatial transcriptomics for mapping circulating tumor cell microenvironment interactions
5.8. Growth in cloud-based data portals offering interactive visualization and cross-study comparison of spatial omics datasets
5.9. Regulatory agencies defining quality control guidelines for spatial transcriptomics assays in clinical diagnostics
5.10. Evolution of nanoprobe technologies facilitating live-cell spatial transcriptomics and temporal gene expression mapping
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Spatial Genomics & Transcriptomics Market, by Product
8.1. Consumables
8.1.1. Assay Kits
8.1.2. Reagents
8.2. Instruments
8.2.1. Microscopes
8.2.2. Sequencing Platforms
8.3. Software
8.3.1. Data Analysis Platforms
8.3.2. Visualization Tools
9. Spatial Genomics & Transcriptomics Market, by Sequencing Method
9.1. In Situ Sequencing
9.2. Multiplexed Error-Robust Fluorescence In Situ Hybridization
9.3. Sequential Fluorescence In Situ Hybridization
9.4. Slide-seq
9.5. Spatial Transcriptomics
10. Spatial Genomics & Transcriptomics Market, by Application
10.1. Cancer Research
10.1.1. Oncology Profiling
10.1.2. Tumor Microenvironment Analysis
10.2. Developmental Biology
10.3. Drug Discovery
10.3.1. Biomarker Analysis
10.3.2. Therapeutic Target Identification
10.4. Immunology
10.5. Neurology
11. Spatial Genomics & Transcriptomics Market, by End-User
11.1. Academic Research Institutions
11.1.1. Biology Departments
11.1.2. Genomics Centers
11.2. Clinical Research Organizations
11.3. Pharmaceutical & Biotechnology Companies
11.4. Research Laboratories
11.4.1. Core Facilities
11.4.2. Private Labs
12. Spatial Genomics & Transcriptomics Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Spatial Genomics & Transcriptomics Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Spatial Genomics & Transcriptomics Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. 10x Genomics, Inc.
15.3.2. Agilent Technologies, Inc.
15.3.3. Akoya Biosciences, Inc.
15.3.4. Becton, Dickinson and Company
15.3.5. Bio-Rad Laboratories, Inc.
15.3.6. Bio-Techne Corporation
15.3.7. Bruker Corporation
15.3.8. Carl Zeiss AG
15.3.9. Danaher Corporation
15.3.10. Evident Corporation
15.3.11. Illumina, Inc.
15.3.12. Indica Labs, Inc.
15.3.13. Ionpath, Inc.
15.3.14. Merck KGaA
15.3.15. Parse Biosciences
15.3.16. PerkinElmer, Inc.
15.3.17. RareCyte, Inc.
15.3.18. Rebus Biosystems, Inc.
15.3.19. Resolve Biosciences GmbH.
15.3.20. S2 Genomics, Inc.
15.3.21. Seven Bridges Genomics
15.3.22. Standard BioTools Inc.
15.3.23. Thermo Fisher Scientific Inc.
15.3.24. Ultivue, Inc.
15.3.25. Vizgen Inc.
List of Tables
List of Figures

Samples

Loading
LOADING...

Companies Mentioned

The key companies profiled in this Spatial Genomics & Transcriptomics market report include:
  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • Akoya Biosciences, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Bruker Corporation
  • Carl Zeiss AG
  • Danaher Corporation
  • Evident Corporation
  • Illumina, Inc.
  • Indica Labs, Inc.
  • Ionpath, Inc.
  • Merck KGaA
  • Parse Biosciences
  • PerkinElmer, Inc.
  • RareCyte, Inc.
  • Rebus Biosystems, Inc.
  • Resolve Biosciences GmbH.
  • S2 Genomics, Inc.
  • Seven Bridges Genomics
  • Standard BioTools Inc.
  • Thermo Fisher Scientific Inc.
  • Ultivue, Inc.
  • Vizgen Inc.

Table Information